Funded by the Stuart Scott Memorial Cancer Research Fund
Multiple myeloma is an incurable cancer of plasma cells. There is no cure for multiple myeloma yet. The T cells of the immune system can protect us in the long term from infections and from cancer. Here, we propose to engineer human T cells so they can recognize and kill myeloma tumor cells. This project will test several ways of engineering the T cells to make them as safe as possible and as effective as possible. Our goal is to use this information to treat human patients with multiple myeloma.
